Activity value 79china Buyer&Supplier,Last transaction date:
2026-06-27
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for zhejian hengkang pharmaceutical co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 27 transactions, with a transaction quantity of 5919.51 and a transaction weight of 511.4.
YearTransactionsQuantityWeight
20255719172.9616711.92
2026275919.51511.4
Bill of lading data
<
1/15
>
Trade date
2026/06/27
B/L No.
106972
Suppliers
zhejian hengkang pharmaceutical co.ltd.
Buyers
instituto quimioterapeutico
Product description
CIPROFIBRATE, SIN MARCA, SIN MODELO BATCH: 303-00260103, FECHA DE FAB: ENERO 2026, FECHA DE VEN: DICIEMBRE 2029 PARA LA FABRICACION DE PRODUCTOS FARMACEUTICOS CIPROFIBRATE, 8 TAMBORES DE 25 KG
Expand
Trade date
2026/06/22
B/L No.
108363177310
Suppliers
zhejian hengkang pharmaceutical co.ltd.
Buyers
công ty cổ phần dược phẩm opv
Product description
Ciprofibrate, nguyên liệu là dược chất để NC và KN thuốc,dạng bột,có STT 232 của DM 7 TT 09/2024/TT-BYT, Batch no: 303-00260101M1,NSX:9/1/2026, HSD: 12/2029,mới 100%,đóng gói: 0.4kg/drums
Expand
Product description
PHARMACEUTICAL RAW MATERIAL FOR THE PHARMACEUTICAL INDUSTRY. DEFERASIROX WITH W/S. FOC SAMPLE FOR TEST ANALYSIS / CLINICAL TRIAL. DRAP CLEARANCE CERTIFICATE ATTACHED.
Expand
Trade date
2026/05/19
B/L No.
amigl260164246a
Suppliers
zhejian hengkang pharmaceutical co.ltd.
Buyers
hizon laboratories inc.
POLs
——
PODs
manila international container terminal
zhejian hengkang pharmaceutical co.ltd. is china Buyer&Supplier,
and primarily engages in the import and export business of products such as pharmaceutical raw material,mesalazine,bat.
According to the 52wmb.com global trade database, as of 2026-06-27, the company has completed 439 international trades,
with its main trading regions covering pakistan,russia,vietnam etc.
The core products include HS29225000,HS29339990,HS29329900 etc,
often transported via hangzhou cn,port hong kong hk, port hangzhou etc,
and its main trading partners are ооо технология лекарств,getz pharma pvt ltd.,ооо алвилс.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on zhejian hengkang pharmaceutical co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.